|
| 35946522 | Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis. | Rheumatology (Oxford) | 2023 |
| 37577680 | CDDO-Methyl Ester Inhibits BRAF Inhibitor Resistance and Remodels the Myeloid Compartment in BRAF-mutant Melanoma. | bioRxiv | 2023 |
| 36964674 | Advances in biological and targeted therapies for systemic sclerosis. | Expert Opin Biol Ther | 2023 |
| 37028702 | Gene Expression Signatures in Inflammatory and Sclerotic Morphea Skin and Sera Distinguish Morphea from Systemic Sclerosis. | J Invest Dermatol | 2023 |
| 36708947 | CXCL9 Links Skin Inflammation and Fibrosis through CXCR3-Dependent Upregulation of Col1a1 in Fibroblasts. | J Invest Dermatol | 2023 |
| 35997480 | Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin. | Arthritis Care Res (Hoboken) | 2023 |
| 36191640 | Senescent Cells Accumulate in Systemic Sclerosis Skin. | J Invest Dermatol | 2023 |
| 35212485 | Self-Assembled Human Skin Equivalents Model Macrophage Activation of Cutaneous Fibrogenesis in Systemic Sclerosis. | Arthritis Rheumatol | 2022 |
| 35751592 | A genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosis. | Rheumatology (Oxford) | 2022 |
| 36355434 | Machine-learning classification identifies patients with early systemic sclerosis as abatacept responders via CD28 pathway modulation. | JCI Insight | 2022 |
| 33164325 | Reply. | Arthritis Rheumatol | 2021 |
| 33654308 | Moving towards a molecular categorization of autoimmune disease. | Nat Rev Rheumatol | 2021 |
| 33663570 | Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis. | Arthritis Res Ther | 2021 |
| 34502134 | SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues. | Int J Mol Sci | 2021 |
| 34179507 | Mast Cell Activation in the Systemic Sclerosis Esophagus. | J Scleroderma Relat Disord | 2021 |
| 34337154 | A Case of Recalcitrant Linear Morphea Responding to Subcutaneous Abatacept. | J Scleroderma Relat Disord | 2021 |
| 33407866 | Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis. | Arthritis Res Ther | 2021 |
| 33028580 | Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement. | Ann Rheum Dis | 2021 |
| 31342624 | Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. | Arthritis Rheumatol | 2020 |
| 34966900 | Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. | Lancet Rheumatol | 2020 |
| 31705627 | Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase-like 4: New Evidence From Three-Dimensional Skin-like Tissues. | Arthritis Rheumatol | 2020 |
| 33164732 | Molecular "omic" signatures in systemic sclerosis. | Eur J Rheumatol | 2020 |
| 32933919 | Machine learning predicts stem cell transplant response in severe scleroderma. | Ann Rheum Dis | 2020 |
| 32721949 | Regulator combinations identify systemic sclerosis patients with more severe disease. | JCI Insight | 2020 |
| 32336038 | Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis. | Arthritis Rheumatol | 2020 |
| 32300202 | CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer. | Sci Rep | 2020 |
| 32134204 | Profibrotic Activation of Human Macrophages in Systemic Sclerosis. | Arthritis Rheumatol | 2020 |
| 32134199 | Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis. | Arthritis Rheumatol | 2020 |
| 30568176 | Lysyl oxidase enzymes mediate TGF-β1-induced fibrotic phenotypes in human skin-like tissues. | Lab Invest | 2019 |
| 31712723 | Shared and distinct mechanisms of fibrosis. | Nat Rev Rheumatol | 2019 |
| 31156645 | OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis. | Front Immunol | 2019 |
| 30920766 | A Machine Learning Classifier for Assigning Individual Patients With Systemic Sclerosis to Intrinsic Molecular Subsets. | Arthritis Rheumatol | 2019 |
| 30799505 | BioMethyl: an R package for biological interpretation of DNA methylation data. | Bioinformatics | 2019 |
| 31112009 | Senescence Signature in Skin Biopsies From Systemic Sclerosis Patients Treated With Senolytic Therapy: Potential Predictor of Clinical Response? | Arthritis Rheumatol | 2019 |
| 30728065 | Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin. | Arthritis Res Ther | 2019 |
| 29073351 | Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial. | Arthritis Rheumatol | 2018 |
| 30498788 | Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung disease. | J Scleroderma Relat Disord | 2018 |
| 29391252 | Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in Skin. | J Invest Dermatol | 2018 |
| 29360996 | Feature specific quantile normalization enables cross-platform classification of molecular subtypes using gene expression data. | Bioinformatics | 2018 |
| 29179949 | Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic Sclerosis. | J Invest Dermatol | 2018 |
| 28011145 | A Functional Genomic Meta-Analysis of Clinical Trials in Systemic Sclerosis: Toward Precision Medicine and Combination Therapy. | J Invest Dermatol | 2017 |
| 28330499 | A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis. | Genome Med | 2017 |
| 28426704 | Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients. | PLoS One | 2017 |
| 28202513 | Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors. | Cancer Res | 2017 |
| 29520335 | The mechanistic implications of gene expression studies in SSc: Insights from Systems Biology. | Curr Treatm Opt Rheumatol | 2017 |
| 29121645 | Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease. | PLoS One | 2017 |
| 28676069 | Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature. | Arthritis Res Ther | 2017 |
| 25384965 | Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression. | Ann Rheum Dis | 2016 |
| 26555452 | Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data. | Curr Opin Rheumatol | 2016 |
| 28018971 | Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. | JCI Insight | 2016 |